GOSSAMER BIO INC (GOSS) Stock Cash Flow
NASDAQ:GOSS - Nasdaq - US38341P1021 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -71.65M | -179.82M | -229.38M | -234.00M | -243.36M | |||
| Depreciation Amortization | 1.01M | 1.61M | 1.83M | 1.74M | 1.41M | |||
| Change In Working Capital | 45.97M | -14.84M | -4.46M | 770.00K | -3.10M | |||
| Interest Paid | 11.02M | 12.29M | 12.71M | 12.74M | 7.87M | |||
| Other non cash items | 23.25M | 33.89M | 44.97M | 42.60M | 68.69M | |||
| OPERATING CASH FLOW | -1.42M | -159.16M | -187.03M | -188.89M | -176.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -410.00K | -1.55M | -1.50M | |||
| Other Investing Activity | -38.56M | -110.97M | -630.00K | -115.88M | 216.85M | |||
| INVESTING CASH FLOW | -38.56M | -110.97M | -1.04M | -117.43M | 215.34M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -15.48M | -11.61M | -5.81M | 0.00 | 193.60M | |||
| Stock Issued/Repurchased | 1.54M | 201.77M | 121.68M | 2.01M | 117.64M | |||
| Other Financing Activity | N/A | N/A | 1.21M | 1.32M | 1.30M | |||
| FINANCING CASH FLOW | -14.39M | 190.15M | 117.09M | 3.33M | 312.54M | |||
| Exchange Rate Effect | 213.00K | 110.00K | -520.00K | -170.00K | 10.00K | |||
| CHANGE IN CASH | -54.16M | -79.86M | -71.50M | -303.16M | 351.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -1.42M | -159.16M | -187.03M | -188.89M | -176.36M | |||
| Capital Expenditure | N/A | 0.00 | -410.00K | -1.55M | -1.50M | |||
| FREE CASH FLOW | -1.42M | -159.16M | -187.44M | -190.44M | -177.86M | |||
All data in USD